drugset / Trial / NCT00666705
A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects
Non-randomizedSingle-groupOpen-label
Summary
An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maraviroc | Other / unclassified | 300 mg | — |
| Subject | Raltegravir | Other / unclassified | 400 mg | — |
Indications
No indication recorded.